Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 469 to 472 of 472 entries
Sorted by: Best Match Show Resources per page
Acute appendicitis during the clinical course of COVID-19 in a 13-year-old boy: Complication or coincidental?.

Surgical practice

Nurullayev E, Gördü B, Özsürekçi Y, Haliloglu M, Soyer T.
PMID: 34899958
Surg Pract. 2021 Sep 30; doi: 10.1111/1744-1633.12526. Epub 2021 Sep 30.

Gastrointestinal symptoms appear to be one of the most common presentations of SARS-CoV-2 infection, later named COVID-19. The symptoms such as nausea, emesis, abdominal pain, and diarrhoea may be recognised as either a finding of COVID-19 or prominent presentation...

Cite
Nurullayev E, Gördü B, Özsürekçi Y, et al. Acute appendicitis during the clinical course of COVID-19 in a 13-year-old boy: Complication or coincidental?. Surg Pract. 2021;doi: 10.1111/1744-1633.12526.
Nurullayev, E., Gördü, B., Özsürekçi, Y., Haliloglu, M., & Soyer, T. (2021). Acute appendicitis during the clinical course of COVID-19 in a 13-year-old boy: Complication or coincidental?. Surgical practice, . https://doi.org/10.1111/1744-1633.12526
Nurullayev, Elnur, et al. "Acute appendicitis during the clinical course of COVID-19 in a 13-year-old boy: Complication or coincidental?." Surgical practice vol. (2021). doi: https://doi.org/10.1111/1744-1633.12526
Nurullayev E, Gördü B, Özsürekçi Y, Haliloglu M, Soyer T. Acute appendicitis during the clinical course of COVID-19 in a 13-year-old boy: Complication or coincidental?. Surg Pract. 2021 Sep 30; doi: 10.1111/1744-1633.12526. Epub 2021 Sep 30. PMID: 34899958; PMCID: PMC8652558.
Copy Download .nbib Format: NLM
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.

Leukemia & lymphoma

Levy I, Lavi A, Zimran E, Grisariu S, Aumann S, Itchaki G, Berger T, Raanani P, Harel R, Aviv A, Lavi N, Zuckerman T, Shvidel L, Jarchowsky O, Ellis M, Herzog Tzarfati K, Koren-Michowitz M, Sherf Y, Levi I, Sofer O, Shpilberg O, Dally N, Suriu C, Braester A, Ben Barouch S, Leiba M, Goldstein D, Sarid N, Yeganeh S, Halloun J, Mittelman M, Tadmor T.
PMID: 34405767
Leuk Lymphoma. 2021 Dec;62(14):3384-3393. doi: 10.1080/10428194.2021.1966782. Epub 2021 Aug 18.

This national Israeli multicenter retrospective study aimed to characterize the clinical course of COVID-19 infection among patients with hematological malignancies, with special emphasis on treatment efficacy and outcome. Clinical and laboratory data from haemato-oncological patients diagnosed with COVID-19 from...

Cite
Levy I, Lavi A, Zimran E, et al. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leuk Lymphoma. 2021;62(14):3384-3393doi: 10.1080/10428194.2021.1966782.
Levy, I., Lavi, A., Zimran, E., Grisariu, S., Aumann, S., Itchaki, G., Berger, T., Raanani, P., Harel, R., Aviv, A., Lavi, N., Zuckerman, T., Shvidel, L., Jarchowsky, O., Ellis, M., Herzog Tzarfati, K., Koren-Michowitz, M., Sherf, Y., Levi, I., Sofer, O., Shpilberg, O., Dally, N., Suriu, C., Braester, A., Ben Barouch, S., Leiba, M., Goldstein, D., Sarid, N., Yeganeh, S., Halloun, J., Mittelman, M., & Tadmor, T. (2021). COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leukemia & lymphoma, 62(14), 3384-3393. https://doi.org/10.1080/10428194.2021.1966782
Levy, Ilana, et al. "COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome." Leukemia & lymphoma vol. 62,14 (2021): 3384-3393. doi: https://doi.org/10.1080/10428194.2021.1966782
Levy I, Lavi A, Zimran E, Grisariu S, Aumann S, Itchaki G, Berger T, Raanani P, Harel R, Aviv A, Lavi N, Zuckerman T, Shvidel L, Jarchowsky O, Ellis M, Herzog Tzarfati K, Koren-Michowitz M, Sherf Y, Levi I, Sofer O, Shpilberg O, Dally N, Suriu C, Braester A, Ben Barouch S, Leiba M, Goldstein D, Sarid N, Yeganeh S, Halloun J, Mittelman M, Tadmor T. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leuk Lymphoma. 2021 Dec;62(14):3384-3393. doi: 10.1080/10428194.2021.1966782. Epub 2021 Aug 18. PMID: 34405767.
Copy Download .nbib Format: NLM
Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program.

Genome medicine

Cade BE, Lee J, Sofer T, Wang H, Zhang M, Chen H, Gharib SA, Gottlieb DJ, Guo X, Lane JM, Liang J, Lin X, Mei H, Patel SR, Purcell SM, Saxena R, Shah NA, Evans DS, Hanis CL, Hillman DR, Mukherjee S, Palmer LJ, Stone KL, Tranah GJ, Abecasis GR, Boerwinkle EA, Correa A, Cupples LA, Kaplan RC, Nickerson DA, North KE, Psaty BM, Rotter JI, Rich SS, Tracy RP, Vasan RS, Wilson JG, Zhu X, Redline S.
PMID: 34446064
Genome Med. 2021 Aug 26;13(1):136. doi: 10.1186/s13073-021-00917-8.

BACKGROUND: Sleep-disordered breathing is a common disorder associated with significant morbidity. The genetic architecture of sleep-disordered breathing remains poorly understood. Through the NHLBI Trans-Omics for Precision Medicine (TOPMed) program, we performed the first whole-genome sequence analysis of sleep-disordered breathing.METHODS:...

Cite
Cade BE, Lee J, Sofer T, et al. Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program. Genome Med. 2021;13(1):136doi: 10.1186/s13073-021-00917-8.
Cade, B. E., Lee, J., Sofer, T., Wang, H., Zhang, M., Chen, H., Gharib, S. A., Gottlieb, D. J., Guo, X., Lane, J. M., Liang, J., Lin, X., Mei, H., Patel, S. R., Purcell, S. M., Saxena, R., Shah, N. A., Evans, D. S., Hanis, C. L., Hillman, D. R., Mukherjee, S., Palmer, L. J., Stone, K. L., Tranah, G. J., Abecasis, G. R., Boerwinkle, E. A., Correa, A., Cupples, L. A., Kaplan, R. C., Nickerson, D. A., North, K. E., Psaty, B. M., Rotter, J. I., Rich, S. S., Tracy, R. P., Vasan, R. S., Wilson, J. G., Zhu, X., Redline, S. (2021). Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program. Genome medicine, 13(1), 136. https://doi.org/10.1186/s13073-021-00917-8
Cade, Brian E, et al. "Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program." Genome medicine vol. 13,1 (2021): 136. doi: https://doi.org/10.1186/s13073-021-00917-8
Cade BE, Lee J, Sofer T, Wang H, Zhang M, Chen H, Gharib SA, Gottlieb DJ, Guo X, Lane JM, Liang J, Lin X, Mei H, Patel SR, Purcell SM, Saxena R, Shah NA, Evans DS, Hanis CL, Hillman DR, Mukherjee S, Palmer LJ, Stone KL, Tranah GJ, Abecasis GR, Boerwinkle EA, Correa A, Cupples LA, Kaplan RC, Nickerson DA, North KE, Psaty BM, Rotter JI, Rich SS, Tracy RP, Vasan RS, Wilson JG, Zhu X, Redline S. Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program. Genome Med. 2021 Aug 26;13(1):136. doi: 10.1186/s13073-021-00917-8. PMID: 34446064; PMCID: PMC8394596.
Copy Download .nbib Format: NLM
Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.

Cancers

Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber ML.
PMID: 34885215
Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236107.

Heterologous prime-boost settings with a protein vaccine and the viral vector vesicular stomatitis virus, both expressing tumor-associated antigens (KISIMA-TAA and VSV-GP-TAA), have been previously shown to generate potent antitumor immunity. In the cold TC-1 model (HPV antigen) and the...

Cite
Hofer T, Rossi M, Carboni S, et al. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236107.
Hofer, T., Rossi, M., Carboni, S., Di Berardino Besson, W., von Laer, D., Wollmann, G., Derouazi, M., & Santiago-Raber, M. L. (2021). Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers, 13(23), . https://doi.org/10.3390/cancers13236107
Hofer, Tamara, et al. "Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236107
Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber ML. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236107. PMID: 34885215; PMCID: PMC8656755.
Copy Download .nbib Format: NLM
Showing 469 to 472 of 472 entries